Crotedumab (Biosimilar Reference Antibody) (GCGR)

CAT: 1609-RA0269-01Size: 100 µgDry Ice: NoHazardous: No

1 / 1

CAT#:1609-RA0269-01Size:100 µg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

CAS Number

1452387-69-7

Synonyms

REGN1193, REGN-1193

Expression System

CHO

Reaction Volume

Human

Immunogen

GCGR

Target

GCGR

Clonality

Monoclonal

Conjugation

Non-conjugated

Type

Antibody

Applications

ELISA; FC ; Functional Assays; IF

Endotoxin

<1.0 EU/mg as determined by LAL method

Purity

>98% by SDS-PAGE

Buffer

0.01M PBS, pH 7.4, contains no stabilizers or preservatives.

Storage Conditions

Store at -20°C or -80°C. Avoid repeated freeze.

Host or Source

Genetically human

Recommended Usage

For research use only

Isotype

IgG4 - kappa

Related Products

Catalog	Name
RA0779-01	Brentuximab (Biosimilar Reference Antibody) (TNFRSF8)
RA0088-01	Brenetafusp (Biosimilar Reference Antibody) (CD3)
RA0365-01	Brazikumab (Biosimilar Reference Antibody) (IL23A)
RA0778-01	Boserolimab (Biosimilar Reference Antibody) (TNFRSF7)
RA0699-01	Blosozumab (Biosimilar Reference Antibody) (SOST)
RA0743-01	Adalimumab (Biosimilar Reference Antibody) (TNF)
RA0131-01	Bezetabart (Biosimilar Reference Antibody) (CD74)
RA0589-01	Zimberelimab (Biosimilar Reference Antibody) (PDCD1)
RA0788-01	Zigakibart (Biosimilar Reference Antibody) (TNFSF13)
RA0111-01	Zanolimumab (Biosimilar Reference Antibody) (CD4)

Catalog	Name
GTR18594609-01	Volagidemab Biosimilar (GCGR Reference Antibody)
GTR18594608-01	Crotedumab Biosimilar (GCGR Reference Antibody)
GTR18580013	GCGR Biosimilar Antibody
M03342-1	Anti-GCGR Reference Antibody (volagidemab)
E24CHA226	Anti-GCGR Reference Antibody (crotedumab)
GTR18781523-01	(Galvokimig2) Biosimilar Reference Antibody
GTR18781412-01	(Fremanezumab) Biosimilar Reference Antibody
GTR18781346-01	(Fiztasovimab) Biosimilar Reference Antibody
GTR18781335-01	(Firivumab) Biosimilar Reference Antibody
GTR18781290-01	(Ficlatuzumab) Biosimilar Reference Antibody